Clinical Trial Detail

NCT ID NCT03344211
Title Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Southern California
Indications

prostate cancer

Therapies

Enzalutamide + Radium Ra 223 dichloride

Enzalutamide

Age Groups: adult senior

No variant requirements are available.